EUVIMEDOpdag EUVIMED
Vergleichsstudie

Comparative Outcomes of Drug‐Eluting Balloons Versus Drug‐Eluting Stents in Patients With Diabetes Undergoing PPCI

Hassan Shabeer, Saba Sattar, F N U Arti, Haimath Kumar iD, Kashif Iltaf, Muhammad Zaryab Haider iD, Burhan Ul Haq Saqib, Muhammad Hassan Bari, Ali Karim iD, Sameet Kumar, F N U Shweta, F N U Payal and 3 more

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.70220 ↗

At a glance

Vergleichsstudie in Catheterization and Cardiovascular Interventions, 2025. Written by Hassan Shabeer and 14 co-authors. Institution: Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan. Major MEDLINE topics: Drug-Eluting Stents, Coronary Artery Disease, Angioplasty, Balloon, Coronary, Coated Materials, Biocompatible. Cited 1 times so far (Crossref); 10 references. Funded by: The authors received no specific funding for this work..

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The comparative outcomes of DEB vs. DES in diabetic patients undergoing PPCI are of significant clinical interest, as these patients often experience higher rates of restenosis and adverse outcomes.

Aims

This study aimed to compare the outcomes of drug‐eluting balloons (DEB) versus drug‐eluting stents (DES) in diabetic patients undergoing primary percutaneous coronary intervention (PPCI).

Methods

We conducted a retrospective analysis of 5668 diabetic patients who underwent PPCI, with 1734 patients in the DEB group and 3934 patients in the DES group. Baseline characteristics, angiographic features, and clinical outcomes, including procedural success, major adverse cardiovascular events (MACE), target lesion revascularization (TLR), restenosis, and bleeding complications, were compared between the two groups.

Results

Both DEB and DES groups demonstrated high procedural success rates (97.6% and 98.4%, respectively), with no significant differences in MACE, death, myocardial infarction, or target vessel revascularization. Restenosis at 6 months occurred in 3.9% of the DEB group and 3.4% of the DES group ( p = 0.21). Lesion length, diabetes duration, hypertension, and prior myocardial infarction were identified as significant predictors of adverse outcomes. Use of DES was associated with a higher risk of MACE, but this did not translate into significant differences in clinical outcomes.

Conclusion

Both DEB and DES are effective and safe treatment options for diabetic patients undergoing PPCI, with comparable outcomes in terms of procedural success, MACE, and restenosis.

Subjects

MeSH terms (MEDLINE)

Drug-Eluting StentsCoronary Artery DiseaseAngioplasty, Balloon, CoronaryCoated Materials, BiocompatibleCardiac CathetersPercutaneous Coronary InterventionDiabetes MellitusHumansRetrospective StudiesMaleFemaleTreatment OutcomeMiddle AgedAgedTime FactorsRisk FactorsProsthesis DesignCoronary AngiographyCoronary Restenosis

Author keywords

diabetesdrug‐eluting balloonsdrug‐eluting stentsmajor adverse cardiovascular eventsprimary percutaneous coronary intervention

Substances

Coated Materials, Biocompatible

Authors and institutions

  • Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan.
  • Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan.

ORCID profiles: Haimath Kumar, Muhammad Zaryab Haider, Ali Karim, Abida Parveen

Funding

  • The authors received no specific funding for this work.

Cite

APA

Shabeer, H., Sattar, S., Arti, F. N. U., Kumar, H., Iltaf, K., Zaryab Haider, M., Haq Saqib, B. U., Hassan Bari, M., Karim, A., Kumar, S., Shweta, F. N. U., Payal, F. N. U., Rumela, F. N. U., Mastoi, M. G., & Parveen, A. (2025). Comparative Outcomes of Drug‐Eluting Balloons Versus Drug‐Eluting Stents in Patients With Diabetes Undergoing PPCI. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70220

Vancouver

Shabeer H, Sattar S, Arti FNU, Kumar H, Iltaf K, Zaryab Haider M, et al. Comparative Outcomes of Drug‐Eluting Balloons Versus Drug‐Eluting Stents in Patients With Diabetes Undergoing PPCI. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70220

BibTeX
@article{Shabeer2025,
  author = {Shabeer, Hassan and Sattar, Saba and Arti, F N U and Kumar, Haimath and Iltaf, Kashif and Zaryab Haider, Muhammad and Haq Saqib, Burhan Ul and Hassan Bari, Muhammad and Karim, Ali and Kumar, Sameet and Shweta, F N U and Payal, F N U and Rumela, F N U and Mastoi, Mehak Gul and Parveen, Abida},
  title = {Comparative Outcomes of Drug‐Eluting Balloons Versus Drug‐Eluting Stents in Patients With Diabetes Undergoing PPCI},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.70220}
}
Start for free →